Gene · 3909
Papers1,589
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,589
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer. | Nat Commun | 2023 | 36774358 | PubTator, text mining | PubMed |
| Patterns of Somatic Variants in Colorectal Adenoma and Carcinoma Tissue and Matched Plasma Samples from the Hungarian Oncogenome Program. | Cancers (Basel) | 2023 | 36765865 | PubTator, text mining | PubMed |
| Generation of Stable Epithelial-Mesenchymal Hybrid Cancer Cells with Tumorigenic Potential. | Cancers (Basel) | 2023 | 36765641 | PubTator, text mining | PubMed |
| Generation of human alveolar epithelial type I cells from pluripotent stem cells. | bioRxiv | 2023 | 36711505 | PubTator, text mining | PubMed |
| Engineering edgeless human skin with enhanced biomechanical properties. | Sci Adv | 2023 | 36706190 | PubTator, text mining | PubMed |
| A temporal classifier predicts histopathology state and parses acute-chronic phasing in inflammatory bowel disease patients. | Commun Biol | 2023 | 36694043 | PubTator, text mining | PubMed |
| Single-cell profiling reveals differences between human classical adenocarcinoma and mucinous adenocarcinoma. | Commun Biol | 2023 | 36690709 | PubTator, text mining | PubMed |
| KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic Strategy, and Potential Treatment Exploration. | J Clin Med | 2023 | 36675641 | PubTator, text mining | PubMed |
| Long-Term Simulation of Microgravity Induces Changes in Gene Expression in Breast Cancer Cells. | Int J Mol Sci | 2023 | 36674696 | PubTator, text mining | PubMed |
| The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. | Curr Oncol | 2023 | 36661697 | PubTator, text mining | PubMed |
| Sustained postconfluent culture of human mammary epithelial cells enriches for luminal and c-Kit+ subtypes. | Breast Cancer Res | 2023 | 36653787 | PubTator, text mining | PubMed |
| A Cdh3-β-catenin-laminin signaling axis in a subset of breast tumor leader cells control leader cell polarization and directional collective migration. | Dev Cell | 2023 | 36626870 | PubTator, text mining | PubMed |
| High cardiomyocyte diversity in human early prenatal heart development. | iScience | 2023 | 36624836 | PubTator, text mining | PubMed |
| Comparative study of differentiating human pluripotent stem cells into vascular smooth muscle cells in hydrogel-based culture methods. | Regen Ther | 2023 | 36618488 | PubTator, text mining | PubMed |
| Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer. | Clin Epigenetics | 2023 | 36611170 | PubTator, text mining | PubMed |
| Clinical and genetic factors associated with radiographic damage in patients with ankylosing spondylitis. | Ann Rheum Dis | 2023 | 36543524 | PubTator, text mining | PubMed |
| Genetic and phenotypic determinants of morphologies in 3D cultures and xenografts of lung tumor cell lines. | Cancer Sci | 2023 | 36533957 | PubTator, text mining | PubMed |
| Extracellular matrix in skin diseases: The road to new therapies. | J Adv Res | 2023 | 36481476 | PubTator, text mining | PubMed |
| The Effect of Extracellular Vesicles on Thrombosis. | J Cardiovasc Transl Res | 2023 | 36441349 | PubTator, text mining | PubMed |
| Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma. | Oncologist | 2023 | 36427020 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3909/papers?page=12